These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2429078)

  • 1. Acute hemodynamic effects of bisoprolol, a new beta 1 selective adrenoreceptor blocking agent, in patients with coronary artery disease.
    Steinmann E; Pfisterer M; Burkart F
    J Cardiovasc Pharmacol; 1986; 8(5):1044-50. PubMed ID: 2429078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of bisoprolol in relation to metoprolol and bufuralol on left ventricular hemodynamics at rest and during exercise in chronic ischemic heart disease.
    Burkart F; Pfisterer M; Steinmann E
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S78-82. PubMed ID: 2439804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic effects of bisoprolol in patients with coronary heart disease: influence of various bisoprolol plasma concentrations.
    Bonelli J; Staribacher H
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S83-6. PubMed ID: 2439805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the potassium channel blocker tedisamil with the beta-adrenoceptor blocker esmolol and the calcium antagonist gallopamil in patients with coronary artery disease.
    Mitrovic V; Oehm E; Thormann J; Pitschner H; Haberbosch W
    Clin Cardiol; 1998 Jul; 21(7):492-502. PubMed ID: 9669058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bisoprolol on cardiac performance in coronary heart disease.
    Maisch B; Borst U; Gerhards W; Wagner G
    Eur J Clin Pharmacol; 1989; 36(3):217-22. PubMed ID: 2568261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisoprolol: a new beta-adrenoceptor blocking drug.
    Prichard BN
    Eur Heart J; 1987 Dec; 8 Suppl M():121-9. PubMed ID: 2897295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic evaluation of bisoprolol after coronary artery surgery in patients with altered left ventricular function.
    Goldstein M; Vincent JL; Le Clerc JL; d'Hollander A; Melot C; Kahn RJ
    Cardiovasc Drugs Ther; 1991 Jun; 5(3):629-33. PubMed ID: 1678965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
    Schnellbacher K; Bestehorn HP; Roskamm H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High beta 1-selectivity and favourable pharmacokinetics as the outstanding properties of bisoprolol.
    Haeusler G; Schliep HJ; Schelling P; Becker KH; Klockow M; Minck KO; Enenkel HJ; Schulze E; Bergmann R; Schmitges CJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S2-15. PubMed ID: 2439793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute systemic and antiischemic effects of epanolol in patients with coronary artery disease.
    Venneker EH; Remme WJ; van Hoogenhuyze DC; Krauss XH; Bartels GL; Kruijssen DA; Storm CJ; van Schelven D
    Cardiovasc Drugs Ther; 1994 Apr; 8(2):211-9. PubMed ID: 7918133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute hemodynamic effects of the vasodilating and beta-blocking agent carvedilol in comparison to propranolol.
    Wendt T; van der Does R; Schräder R; Landgraf H; Kober G
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S147-50. PubMed ID: 2454362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of bisoprolol on exercise tolerance in patients with coronary heart disease: placebo-controlled double-blind crossover study.
    Schnellbacher K; Marsovszky E; Roskamm H
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S143-7. PubMed ID: 2439786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bisoprolol on blood pressure and arterial hemodynamics in systemic hypertension.
    Asmar RG; Kerihuel JC; Girerd XJ; Safar ME
    Am J Cardiol; 1991 Jul; 68(1):61-4. PubMed ID: 1676238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rest and exercise haemodynamic evaluation of a new cardio-selective beta-adrenoceptor blocker celiprolol alone and in combination with nitroglycerine in ischaemic heart disease.
    Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH
    Br J Clin Pharmacol; 1986 Dec; 22(6):697-706. PubMed ID: 2882772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-response relationship of the beta-adrenoceptor antagonist bisoprolol in patients with coronary heart disease and chronic obstructive bronchitis.
    Dorow P; Tönnesmann U
    Eur J Clin Pharmacol; 1984; 27(2):135-9. PubMed ID: 6149938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of dopexamine on the hemodynamics of coronary surgery patients with and without bisoprolol blockade].
    Günnicker M; Freund U; Grebe EJ; Scherer R; Schieffer M; Zerkowski HR; Hess W
    Z Kardiol; 1993 Nov; 82(11):729-36. PubMed ID: 7904788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Summary of short- and long-term studies with bisoprolol in coronary heart disease (CHD).
    Wagner G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S160-6. PubMed ID: 2439790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Important differences between short- and long-term hemodynamic effects of amiodarone in patients with chronic ischemic heart disease at rest and during ischemia-induced left ventricular dysfunction.
    Pfisterer M; Burkart F; Müller-Brand J; Kiowski W
    J Am Coll Cardiol; 1985 May; 5(5):1205-11. PubMed ID: 3989133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential actions of atenolol and celiprolol on cardiac performance in ischemic heart disease.
    Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S138-44. PubMed ID: 2427845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hemodynamic effects of bufuralol: a beta-adrenoceptor blocking drug with vasodilatory effects.
    Pfisterer M; Burckhardt D; Bühler FR; Burkart F
    J Cardiovasc Pharmacol; 1984; 6(3):417-22. PubMed ID: 6202966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.